New research funded by the NIHR Health Technology Assessment (HTA) programme suggests that using bedside pulmonary artery catheterisation (PAC) in the management of critically ill patients provides no demonstrable benefit for patients. Researchers found no evidence that PAC, which has been the standard of care for people in intensive care units (ICUs) for nearly 30 years, enable patients to recover faster or improve survival. [click link for full article]